{{Rsnum
|rsid=583583
|Gene=BCL9
|Chromosome=1
|position=147611315
|Orientation=minus
|GMAF=0.2718
|Gene_s=BCL9
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.6 | 41.6 | 47.8
| HCB | 8.8 | 41.6 | 49.6
| JPT | 0.9 | 39.8 | 59.3
| YRI | 6.1 | 35.4 | 58.5
| ASW | 12.3 | 21.1 | 66.7
| CHB | 8.8 | 41.6 | 49.6
| CHD | 10.1 | 38.5 | 51.4
| GIH | 13.9 | 46.5 | 39.6
| LWK | 4.5 | 29.1 | 66.4
| MEX | 10.5 | 47.4 | 42.1
| MKK | 6.4 | 47.4 | 46.2
| TSI | 3.9 | 50.0 | 46.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23382809
  |Trait=Schizophrenia (negative symptoms)
  |Title=BCL9 and C9orf5 are associated with negative symptoms in schizophrenia: meta-analysis of two genome-wide association studies.
  |RiskAllele=A
  |Pval=6E-7
  |OR=1.30
  |ORtxt=[NR]
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}